Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 30, Issue 4, Pages 552-559
Publisher
Wiley
Online
2015-01-15
DOI
10.1002/mds.26152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Application of New Cholesterol Guidelines to a Population-Based Sample
- (2014) Michael J. Pencina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological Implications
- (2013) Honglei Chen et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- More Than a Billion People Taking Statins?
- (2013) John P. A. Ioannidis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Holding on to statins in Parkinson disease
- (2013) E.-K. Tan et al. NEUROLOGY
- Discontinuation of statin therapy associates with Parkinson disease: A population-based study
- (2013) Y.-C. Lee et al. NEUROLOGY
- Prospective Study of Statin Use and Risk of Parkinson Disease
- (2012) Xiang Gao ARCHIVES OF NEUROLOGY
- Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses
- (2011) Junqiang Yan et al. PLoS One
- Cholesterol metabolism in neurons and astrocytes
- (2011) Frank W. Pfrieger et al. PROGRESS IN LIPID RESEARCH
- Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
- (2010) Yoshihiro Miyake et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Statin use and Parkinson's disease in Denmark
- (2010) Beate Ritz et al. MOVEMENT DISORDERS
- Statin Adverse Effects
- (2009) Beatrice A Golomb et al. American Journal of Cardiovascular Drugs
- Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies
- (2009) Andrew O. Koob et al. EXPERIMENTAL NEUROLOGY
- Use of Statins and the Risk of Parkinson???s Disease
- (2008) Claudia Becker et al. DRUG SAFETY
- Statin use and the risk of Parkinson disease: a nested case control study
- (2008) Ali Samii et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease
- (2008) Pazit Bar-On et al. JOURNAL OF NEUROCHEMISTRY
- Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study
- (2008) Xuemei Huang et al. MOVEMENT DISORDERS
- Statin use and the risk of Parkinson disease
- (2008) A. D. Wahner et al. NEUROLOGY
- Total cholesterol and the risk of Parkinson disease
- (2008) G. Hu et al. NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started